MedPath

Homoeopathic treatment of depressio

Phase 2
Conditions
Health Condition 1: null- Moderate depression
Registration Number
CTRI/2018/05/014102
Lead Sponsor
ational Institute of Homoeopathy Ministry of AYUSH Govt of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Cases suffering from depression, diagnosed as per DSM-V criteria [18]

2. Moderate cases of depression (HRDS scores 14 to 18)

3. Patients must not have been taking antidepressants or anxiolytic drugs at the time of inclusion

4. Both male and female patients

5. Age between 18 and 65 years

6. Capability and willingness to give informed consent and to comply with the study procedures

7. Literate patients who can read English and/or Bengali

Exclusion Criteria

1. Mild (HRDS 13 or less) cases of depression

2. Severe or very severe depression (HRDS more than 19); with or without suicide attempt

3. Spontaneous improvement by 25% or more in HDRS during the 1-week placebo run-in prior trial enrolment

4. Patients with other psychiatric diseases; e.g. schizophrenia or other psychotic disorders, bipolar affective disorder, schizoaffective disorders, alcohol or other substance abuse, eating disorders, psychosis, mania, hypomania or any other Axis I disorder except panic disorder, personality disorders, history of seizures

5. A clinically significant acute or chronic disease that would hinder regular participation in the study

6. Treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening

7. Complementary or alternative treatment used simultaneously to the study (for example acupuncture, phytotherapy, psychotherapy etc.)

8. Homeopathic treatment for any chronic diseases eight weeks prior to study entry

9. Cases suffering from uncontrolled systemic illness or life-threatening infections

10. Self-reported immune-compromised state

11. Pregnant women and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hamiltonâ??s Depression Rating Scale (HDRS)Timepoint: Baseline, every month, up to 3 months
Secondary Outcome Measures
NameTimeMethod
Beckâ??s Depression Inventory (BDI)Timepoint: Baseline, every month, up to 3 months;Montgomery-Ã?sberg Depression Scale (MADRS)Timepoint: Baseline, every month, up to 3 months;Patients Health Questionnaire â?? 9 (PHQ-9)Timepoint: Baseline, every month, up to 3 months
© Copyright 2025. All Rights Reserved by MedPath